GlassScriptPhysician profile
Kathi A Lutz
NPI 1861461071
$1,379.27
in general payments reported to CMS, 2019-2025
18 companies · $163 in 2025
The $163 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $288 · 2022: $207 · 2023: $505 · 2024: $217 · 2025: $163.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $885.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $884.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $280.02 | 2022-2025 | Camzyos, Eliquis |
| Amgen INC. | $209.93 | 2023-2025 | Repatha |
| Janssen Pharmaceuticals, INC | $140.83 | 2022-2023 | Xarelto |
| Edwards Lifesciences Corporation | $133.98 | 2023-2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Boehringer Ingelheim Pharmaceuticals, INC. | $117.42 | 2021-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $107.42 | 2021-2022 | |
| Abbott Laboratories | $88.27 | 2021-2022 | |
| Biosense Webster, INC. | $59.06 | 2022-2023 | Octaray Mapping Catheter |
| Novo Nordisk INC | $49.88 | 2024-2025 | Wegovy |
| Novartis Pharmaceuticals Corporation | $44.79 | 2022-2024 | |
| Abiomed | $41.76 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $22.18 | 2024 | Lifevest |
| Merck Sharp & Dohme LLC | $16.67 | 2023 | Verquvo |
| Sanofi-Aventis U.S. LLC | $15.04 | 2024 | |
| Daiichi Sankyo INC. | $14.52 | 2023 | Injectafer |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $13.73 | 2021 | |
| Pfizer INC. | $12.64 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $11.13 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathi Lutz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.